This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q20.0 (common arterial trunk) | Special Copayment Reduction: V144 (rare disease) |
| B. Synonyms | Truncus arteriosus communis, persistent truncus arteriosus |
| C. Adult onset | Likelihood of first onset in adulthood: low — common arterial trunk (single truncal artery) is almost invariably diagnosed in the neonatal period or early infancy because of cyanosis and heart failure right after birth. Survival into adulthood without surgical repair is extremely rare. Patients who reach adulthood after corrective surgery may develop new cardiac complications, but this is progression of residual postoperative lesions, not adult 're-presentation'. |
| 1. History | 1798 first autopsy description by Wilson. 1949 Collett-Edwards classification. 1968 first complete repair by McGoon. Standardized after Rastelli conduit repair in 1984. |
| 2. Causes | Failure of outflow tract septum (conal/truncal septum) formation. Impaired neural crest cell migration (associated with 22q11.2 deletion in about 30%). Abnormalities in NKX2.5, GATA4, TBX1 pathways. Environmental factors such as diabetes and valproic acid. |
| 3. Genetics | 22q11.2 deletion syndrome (DiGeorge) in about 30%. Key role of the TBX1 gene. Associations with NKX2.5, GATA4, JAG1 variants. Mostly de novo. Chromosomal microarray recommended. |
| 4. General epidemiology | About 0.7~1.2% of all congenital heart disease. About 0.5~1 per 10,000 births. Equal in males and females. Increased risk of other associated anomalies when 22q11.2 deletion is present. |
| 5. Pathophysiology | Complete failure of outflow tract septum (aorticopulmonary septum) formation at 4~8 weeks of gestation → aorta·pulmonary artery arise from a common single trunk. Associated ventricular septal defect. Truncal valve abnormality (truncal valve regurgitation) frequent. |
| 6. Symptoms | In the neonatal period~within a few weeks of birth: cyanosis (mild), tachypnea, poor feeding, sweating, heart failure (pulmonary overcirculation). The degree of cyanosis varies by Collett-Edwards Type I~IV. |
| 7. Signs | Heart murmur (continuous or systolic), cardiomegaly, jugular venous distension, hepatomegaly. Chest X-ray: cardiomegaly·increased pulmonary vascularity. Echocardiography: common single trunk, VSD, truncal valve. |
| 8. Screening | Fetal echocardiography (18~22 weeks of gestation). Newborn pulse oximetry screening. Immediate echocardiography in neonates with cyanosis·heart murmur. Concurrent 22q11.2 deletion testing. |
| 9. Diagnosis | Echocardiography (confirmation and anatomical classification). Cardiovascular CT/MRI (to define pulmonary artery origins and coronary artery course). Cardiac catheterization (measurement of pulmonary vascular resistance). Chromosomal microarray. |
| 10. Treatment | Complete repair within 1~2 months of birth: VSD closure + right ventricle-pulmonary artery conduit (RV-PA conduit) insertion (Rastelli type). Valvuloplasty·replacement when truncal valve regurgitation is severe. Palliative surgery is now rarely used. |
| 11. Prognosis | 10-year survival after modern repair 80~85%. Major long-term issues: reoperation for conduit stenosis/failure (about 50% within 10 years), progression of truncal valve regurgitation, management of heart failure·arrhythmias in adulthood. |
| 12. Prevention | Genetic counseling for families with 22q11.2 deletion. Preconception diabetes control, avoidance of valproic acid. Early fetal echocardiography. Regular echocardiographic follow-up of adult repaired patients. |
| 13. References | Collett RW, Edwards JE 1949; McGoon DC et al. 1968; Van Praagh R, Van Praagh S 1965 and 7 others |
Common arterial trunk (truncus arteriosus) is a rare congenital heart malformation in which the aorta and pulmonary artery are not separated and arise from the heart as a single common great vessel. The first pathological-anatomical description of this malformation was made in 1798 by the British surgeon John Wilson. During the 19th century, several pathologists reported similar cases, and in 1942 Beck (Lev and Saphir) and in 1949 Collett·Edwards published a Type I~IV classification system based on the pattern of vessel origin. This classification remains the most widely used in clinical practice today.
Physiological understanding advanced rapidly from the 1960s with the development of cardiac catheterization. In 1965, Van Praagh modified the Collett-Edwards classification and proposed an embryological classification of common arterial trunk. Definitive surgical repair began in 1968 when Donald McGoon and colleagues at the Mayo Clinic in the United States first successfully performed complete repair — closure of the ventricular septal defect (VSD) and insertion of a right ventricle-pulmonary artery conduit (RV-PA conduit). This operation applied Giacomo Rastelli's principle of outflow tract reconstruction.
In the 1970s~80s, with improvements in cardiopulmonary bypass technology and advances in neonatal cardiac surgical techniques, the timing of surgery gradually moved earlier. Early complete repair within 1~2 months of birth is now recommended as standard. Long-term follow-up outcomes have improved along with advances in conduit materials (homograft conduits, bovine pericardial conduits, prosthetic conduits). The association between 22q11.2 deletion syndrome (DiGeorge syndrome) and common arterial trunk was established in the 1990s, and chromosomal microarray testing is recommended in all patients with common arterial trunk. In Korea, outcomes of early repair have improved greatly with the development of pediatric cardiac surgery, and copayment reduction benefits are provided upon registration as a rare disease eligible for Special Copayment Reduction V144.
The heart develops from embryonic cardiac precursor cells at 3~8 weeks of gestation and is completed through complex processes of division·transposition·looping. Formation of the cardiac tube (gestational days 22~23), looping (gestational days 23~28), atrial·ventricular septation (4~7 weeks of gestation), and outflow tract septation proceed sequentially, and abnormalities of the genetic factors and signaling pathways involved in these processes cause transposition of the great arteries, double outlet ventricle, and others. Cardiac neural crest cells play a key role in outflow tract septation.
Common arterial trunk is a congenital malformation in which the outflow tract septum (aorticopulmonary septum, or truncoconal septum) fails to form completely at 4~8 weeks of gestation, so the aorta and pulmonary artery remain a single common vessel. In normal development, this septum forms in a spiral through the migration and proliferation of cardiac neural crest cells and divides the outflow tract into the aorta and pulmonary artery. Complete failure of this process results in common arterial trunk.
Genetic factors: 22q11.2 deletion is present in about 30~40% of patients with common arterial trunk. In 22q11.2 microdeletion (DiGeorge syndrome, velocardiofacial syndrome), the TBX1 gene located in this region plays a key role. TBX1 is a transcription factor that regulates cardiac neural crest cell migration and pharyngeal arch development, and deletion of this gene causes abnormal outflow tract formation and common arterial trunk. Variants in cardiac developmental transcription factors such as NKX2.5, GATA4, HAND1, and HAND2 are also associated with outflow tract malformations including common arterial trunk. JAG1 (Alagille syndrome-related) variants have also been reported in some cases of common arterial trunk.
Environmental factors: maternal diabetes, valproic acid exposure, retinoid exposure, and rubella infection in early pregnancy increase the risk of congenital heart malformations in general. Alcohol consumption and hyperthermia in early pregnancy are also reported as risk factors. Specific environmental factors for common arterial trunk itself have not yet been fully identified, but factors affecting neural crest cell development are understood to be involved.
In the genetic architecture of common arterial trunk, the most important related condition is 22q11.2 deletion syndrome. 22q11.2 deletion is identified in about 30~40% of patients with common arterial trunk. This deletion mostly arises as a de novo mutation, but about 10% are inherited from a parent. 22q11.2 deletion itself occurs at a frequency of about 1 in 3,000~4,000 people, and among patients with this deletion, common arterial trunk is one of the rarer malformations. The TBX1 gene (located at 22q11.21) is the key causative gene, regulating cardiac neural crest cell migration, pharyngeal arch development, and outflow tract septum formation. Isolated TBX1 deletion reproduces most of the 22q11.2 phenotype, characterized by cardiac malformations·parathyroid hypoplasia·T-cell immunodeficiency·palatal anomalies.
NKX2.5 is one of the most essential transcription factors in cardiac development, and variants in this gene are associated with various structural heart malformations along with atrioventricular conduction disorders. GATA4 is an early transcription factor in cardiac development, and heterozygous GATA4 variants are associated with ventricular septal defects·atrial septal defects, including common arterial trunk. Variants in the FOXC1 and FOXC2 genes are also related to great vessel malformations. Chromosomal microarray (CMA) is the standard test for detecting microdeletions·duplications including 22q11.2 deletion and is recommended for all neonates with common arterial trunk. When a 22q11.2 deletion is confirmed, parental testing is also performed.
Common arterial trunk accounts for about 0.7~1.2% of all congenital heart disease and is a rare congenital heart malformation occurring at a frequency of about 0.5~1 per 10,000 births. The annual number of neonates with common arterial trunk worldwide is estimated at about 3,000~5,000. Incidence is equal in males and females, and no clear differences by race have been reported. In patients with associated 22q11.2 deletion, additional associated abnormalities such as immune abnormalities, hypocalcemia, and palatal anomalies are more frequent.
Collett-Edwards classification: Type I (main pulmonary artery arises from the common arterial trunk, about 48%), Type II (left·right pulmonary arteries arise separately from the posterior aspect of the common arterial trunk, about 29%), Type III (left·right pulmonary arteries arise separately from the lateral aspects of the common arterial trunk, about 11%), Type IV (actually pulmonary atresia with aortopulmonary collateral vessels, sometimes excluded when classified separately). In Korea, common arterial trunk (Q20.0) is eligible for rare disease Special Copayment Reduction V144. The overall incidence of congenital heart disease is about 8~10 per 1,000 births, and common arterial trunk is among the rarer subtypes.
The core pathogenesis of common arterial trunk is failure of formation of the outflow tract septum (aorticopulmonary septum). In normal development, at 4~8 weeks of gestation, cardiac neural crest cells migrate from the pharynx to the cardiac outflow tract, and these cells interact with endocardial cushion cells to form a spiral septum. As this septum grows in a spiral, it divides the outflow tract into the aorta and pulmonary artery. If there is a defect in the migration·proliferation·differentiation of neural crest cells, the septum does not form and common arterial trunk results.
A ventricular septal defect (VSD) is almost always present in common arterial trunk. The VSD is an outlet (subarterial) VSD located just below the common arterial trunk. The common truncal valve has various forms, including bicuspid, tricuspid, and quadricuspid, and valve regurgitation is present in about 30~40%. Anomalous coronary artery origin (abnormal origin from the conus-trunk) is also an anatomical variant important for surgical planning. In common arterial trunk, pulmonary blood flow is supplied at systemic pressure, so pulmonary overcirculation and pulmonary hypertension progress from early on, and if repair is delayed, pulmonary vascular obstructive disease (Eisenmenger syndrome) develops.
The clinical symptoms of common arterial trunk appear in the neonatal period~within a few weeks of birth as pulmonary overcirculation and heart failure. Because the aorta and pulmonary artery are supplied from the common single trunk, systemic and pulmonary blood mix, causing mild cyanosis, while at the same time pulmonary blood flow is excessive and symptoms of pulmonary edema·heart failure predominate.
Neonatal symptoms: cyanosis is initially mild (or, with pulmonary overcirculation, the infant may even appear pink) or not obvious. Tachypnea, tachycardia, poor feeding, excessive sweating, and poor weight gain appear. Respiratory distress due to pulmonary edema and heart failure gradually worsens after 2~4 weeks of age. As pulmonary vascular resistance normally falls after birth, pulmonary overcirculation becomes even more severe. When truncal valve regurgitation is severe, heart failure worsens early.
Associated symptoms: when 22q11.2 deletion is present, hypocalcemia (seizures, tetany), immunodeficiency (T-cell deficiency, recurrent infections), palatal anomalies (cleft palate, velopharyngeal insufficiency), facial anomalies (ear abnormalities, exotropia, small ears, low-set ears), and developmental delay may be present. When these symptoms are present, 22q11.2 deletion should be actively suspected and tested for.
On physical examination, a systolic or continuous heart murmur may be heard at the left sternal border on auscultation, and a diastolic murmur is added if there is truncal valve regurgitation. The ECG may show biventricular hypertrophy. Chest X-ray shows cardiomegaly, pulmonary plethora, and absent thymic shadow (with 22q11.2 deletion). Oxygen saturation initially shows a mild decrease (85~95%) or is nearly normal, and the decrease becomes more pronounced as pulmonary edema worsens with pulmonary overcirculation.
Echocardiographic findings: a single great vessel arising from the ventricles, with the pulmonary artery arising from that great vessel, is the confirmatory finding. A VSD (outlet type) is identified just below the common single trunk. Truncal valve morphology (bicuspid~quadricuspid), the degree of regurgitation, and the location of coronary artery origins are evaluated. Pulmonary artery anatomy (Type I~III) is precisely classified.
Prenatal screening for common arterial trunk is performed by detailed fetal echocardiography at 18~22 weeks of gestation. When a single great vessel arising from the ventricles is suspected on the 4-chamber view, the 5-vessel view and short-axis view are added to confirm common arterial trunk. The prenatal detection rate of common arterial trunk on fetal echocardiography is reported to be about 60~80%. After prenatal diagnosis, fetal chromosomal microarray is used to check for 22q11.2 deletion. Delivery is planned at a tertiary medical institution with pediatric cardiac surgery.
Pulse oximetry screening performed in all newborns after birth is useful for screening cyanotic heart malformations including common arterial trunk. In common arterial trunk, if the initial oxygen saturation is borderline or there is a heart murmur or respiratory abnormality, echocardiography is performed immediately.
Echocardiography is the standard test for diagnosis and anatomical classification of common arterial trunk. 2D·color Doppler·continuous-wave Doppler echocardiography is used to confirm the single great vessel and to evaluate the type of pulmonary artery origin (Type I~III), VSD location·size, truncal valve morphology·degree of regurgitation, location of coronary artery origins, and ventricular function.
Cardiovascular CT or MRI is used complementarily for preoperative evaluation of pulmonary artery branch anatomy, coronary artery course, and bronchial·airway structures. Cardiac catheterization is performed to measure pulmonary vascular resistance (Qp/Qs ratio, pulmonary vascular resistance index) and assess pulmonary artery reactivity. It is important for determining whether pulmonary vascular resistance is at a level contraindicating surgery (>8 Wood units·m²). Chromosomal microarray is standard for detecting 22q11.2 deletion and other microdeletions·duplications.
The definitive treatment for common arterial trunk is surgical complete repair. Because most die within the first year of life without surgery, early surgery is essential.
Complete repair: standard practice is to perform it within 1~2 months of birth. The key elements of the operation are ① closing the VSD with a patch so that the truncal artery arises only from the left ventricle (conversion to the aorta), and ② separating the pulmonary arteries from the trunk and connecting them with a right ventricle-pulmonary artery conduit (RV-PA conduit). This procedure is based on the Rastelli principle. When truncal valve regurgitation is moderate or greater, valve repair or valve replacement is performed at the same time. If there is anomalous coronary artery origin, coronary translocation is needed.
Conduit reoperation: reoperation on the right ventricle-pulmonary artery conduit is inevitable because of conduit stenosis and regurgitation with growth. Conduit replacement surgery is needed in childhood~adolescence, and recently transcatheter pulmonary valve implantation (TPVI/PPVI) has been used as an alternative to conduit reoperation. In patients with 22q11.2 deletion, when homograft conduits are used, conduit dysfunction tends to develop early because of immune reactions.
Treatment related to 22q11.2 deletion: hypocalcemia is managed with calcium·vitamin D supplementation, T-cell immunodeficiency with contraindication of live vaccines and gamma globulin replacement, and velopharyngeal insufficiency with speech therapy·surgery.
Before the era of corrective surgery, about 65% of patients with common arterial trunk died within 6 months of birth. Early mortality after modern complete repair is about 5~10% (surgical mortality), and 10-year survival has improved to about 80~85%.
Major long-term issues: reoperation for right ventricle-pulmonary artery conduit stenosis/regurgitation is the most common long-term issue, with more than about 50% requiring conduit reoperation or transcatheter pulmonary valve implantation within 10 years. Progression of truncal valve regurgitation, reduced left ventricular function, arrhythmias (atrial fibrillation, ventricular arrhythmias), and progression of pulmonary hypertension are issues in adulthood. In patients with associated 22q11.2 deletion, neurocognitive development, psychiatric problems (increased risk of schizophrenia, anxiety disorders), and recurrent infections additionally affect quality of life. Long-term follow-up at an adult congenital heart disease clinic is essential.
Specific primary prevention of common arterial trunk is difficult. In families in which a 22q11.2 deletion has been identified, genetic counseling explains the recurrence risk (50% risk for children of an affected parent) and offers preimplantation genetic testing (PGT) or prenatal diagnosis. Preconception diabetes control, avoidance of valproic acid, and confirmation of rubella vaccination before early pregnancy contribute to reducing the risk of congenital heart malformations in general. Early diagnosis by detailed fetal echocardiography (18~22 weeks of gestation), followed by planned delivery and immediate surgical preparation at a specialized tertiary institution, is key to improving prognosis. For adult patients after corrective surgery, follow-up at an adult congenital heart disease outpatient clinic, including regular echocardiography, ECG, exercise testing, and assessment of pulmonary vascular resistance, is essential for early detection and prevention of complications.